| original | translation |
|----------|-------------|
| This has been bugging me for years now, and I thought one of you fine people would know - in Eclipse's .classpath files, what is the combineaccessrules attribute of the classpathentry element actually used for?<br/><br/>I can see in the Java Build Path config dialog that it can be maniuplated, but I can't think of a good use case for it. If I muck about with the settings, or modify the .classpath file manually, it doesn't seem to have any effect.<br/><br/>I'm hoping someone else has put it to good use, and I can steal their ideas. Basically, it's an itch I'm trying to scratch.<br/><br/>3 Answers<br/><br/>With proper use of access rules you can prevent using "internal" and/or "non-api" classes and methods. When you add a class or package as Forbidden or Discouraged the compiler show an error or warning when you use that class or class from the specified package. For a longer introduction of access rules you should read this short article.<br/><br/>For using combine access rules imagine the following situation:<br/><br/>You have 2 projects, A and B.<br/><br/>On the classpath of project A there is a jar file that is exported. The jar contains some "stable api", "unstable api" and "non-api" public classes.<br/><br/>Project B depends on project A.<br/><br/>You do not allow using "non-api" classes in project A so you set some Forbidden access rules on those classes / packages.<br/><br/>In project B you do not allow using "non-api" as well, but you do want to get a warning when using "unstable api". In this case in project B you only have to set the additional Discouraged access rules if you check the Combine rules with the access rules of the exported project entries.<br/><br/>Access rules are handy little things, but dangerous. They exclude a source file from the project compiler but leave the file intact in the filesystem.<br/><br/>The project I work on has a bootstrap class in one of our source folders, but if we include the entire folder the project classpath it won't compile (it's a long story and the build process handles this).<br/><br/>So we use an eclipse access rule to exclude it and it never bothers us during development. This means we can't easily change the code, but it's one of those classes that literally hasn't been touched in years.<br/><br/>Combine Access Rules, judging by the JavaDoc, is a real edge use case. To use it you would have to have:<br/><br/>an access rule in an exported source entry of one project<br/><br/>a link to that project from a parent project<br/><br/>a need to combine the access rules of the sub project with the parent<br/><br/>I really can't say how it would be useful, but I hope that at least answers your "what is it" question :) | Isto estivo molestándome durante anos, e pensei que unha boa persoa sabería - nos ficheiros .classpath de Eclipse, cal é o atributo combineaccessrules do elemento classpathentry realmente usado?<br/><br/>Podo ver no diálogo de configuración de Java Build Path que pode ser manipulado, pero non podo pensar nun bo caso de uso para iso. Se fago un lixo coa configuración, ou modifico o ficheiro. classpath manualmente, non parece ter ningún efecto.<br/><br/>Espero que alguén o poida usar ben, e poida roubarlle as súas ideas.<br/><br/>3 Respostas<br/><br/>Co uso correcto das regras de acceso podes evitar o uso de clases e métodos "internos" e/ou "non-api". Cando engade unha clase ou paquete como Prohibido ou Desaconsellado, o compilador mostra un erro ou aviso cando usa esa clase ou clase do paquete especificado. Para unha introdución máis longa das regras de acceso debería ler este breve artigo.<br/><br/>Para usar as regras de acceso combinado imaxina a seguinte situación:<br/><br/>Hai dous proxectos, A e B.<br/><br/>No camiño de clase do proxecto A hai un ficheiro jar que se exporta. O xar contén algunhas clases públicas "api estable", "api inestable" e "non-api".<br/><br/>O Proxecto B depende do Proxecto A.<br/><br/>Non permite usar clases "non-api" no proxecto A polo que establece algunhas regras de acceso Prohibido nesas clases/paquetes.<br/><br/>No proxecto B non se permite usar "non-api" tamén, pero se quere obter unha advertencia cando se usa "api inestable". Neste caso no proxecto B só tes que configurar as regras adicionais de acceso desaconsellado se revisas as regras de combinación coas regras de acceso das entradas do proxecto exportadas.<br/><br/>As regras de acceso son pequenas cousas útiles, pero perigosas. Exclúen un ficheiro de orixe do compilador do proxecto pero deixan o ficheiro intacto no sistema de ficheiros.<br/><br/>O proxecto no que traballo ten unha clase bootstrap nun dos nosos cartafoles de orixe, pero se incluímos todo o cartafol o camiño de clase do proxecto non o compilará (é unha longa historia e o proceso de construción manexa isto).<br/><br/>Así que usamos unha regra de acceso á eclipse para excluíla e nunca nos molesta durante o desenvolvemento. Isto significa que non podemos cambiar facilmente o código, pero é unha daquelas clases que literalmente non se tocaron en anos.<br/><br/>Combinar as regras de acceso, a xulgar polo JavaDoc, é un caso real de uso do bordo. Para usalo terías que ter:<br/><br/>unha regra de acceso nunha entrada de orixe exportada dun proxecto<br/><br/>unha ligazón a ese proxecto desde un proxecto pai<br/><br/>a necesidade de combinar as regras de acceso do subproxecto co pai<br/><br/>Non podo dicir como sería útil, pero espero que polo menos responda a túa pregunta "que é" :) |
| Clues to heart disease in unexpected places, researchers discover<br/><br/>A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented with new medicines. Now, the researchers are one step closer to achieving that goal, thanks to their discovery of a key molecule in an unexpected place in heart cells – mitochondria, tiny energy factories that house the controls capable of setting off cells' self-destruct sequence.<br/><br/>The study is the first to identify the molecule, an enzyme known as GRK2 (G protein-coupled receptor kinase 2), in mitochondria. It was led by Walter J. Koch, Ph.D., Professor and Chairman of the Department of Pharmacology at TUSM, and Director of the Center for Translational Medicine at TUSM.<br/><br/>"We have known that GRK2 is involved in the pathological development of certain heart diseases, such as chronic heart failure, and that its increased activity can lead to the death of heart cells. But its mechanism for the latter was unclear," Koch said. In addition, while the enzyme was known to be present in elevated levels in the hearts of patients with heart failure, the reasons for its rise were not fully understood.<br/><br/>Normally, GRK2 hangs out near the plasma membrane of heart cells, where it turns off certain signals transferred from the blood to the tissue. But the researchers at Temple found that it moves to mitochondria in response to two classic features of heart disease, ischemic insult and ensuing oxidative stress. These two processes, in which a momentary lapse in the delivery of oxygen-rich blood to diseased tissues causes a sudden increase in damaging reactive molecules, converge to stimulate the self-destruct program of heart cells. They ultimately cause whole sections of heart tissue to die, leaving behind scars that can severely compromise the ability of the heart to function properly.<br/><br/>Koch's team found that in ischemic heart cells the movement of GRK2 from the cell membrane to mitochondria is chaperoned by a substance called heat-shock protein 90 (Hsp90), which is produced in cells in response to stress. By blocking Hsp90's ability to bind to GRK2, the researchers were able to prevent the enzyme's delivery to mitochondria.<br/><br/>They reached the same result after mutating a residue called Ser670 in the tail end of GRK2's amino acid structure. When the Ser670 residue is activated by a chemical signal, Hsp90 is nudged into action, attaching to GRK2 and carrying it to mitochondria. Mutation of Ser670 also resulted in a wholesale reduction in pro-death signaling in affected heart cells. The effects were observed in human heart muscle cells grown in the laboratory and in mice that had experienced induced heart attacks. The results are detailed in the April 12 issue of the journal Circulation Research.<br/><br/>Koch explained that the translation of the new findings to the clinic, where they would benefit patients, lies in developing new therapeutic approaches that are capable of limiting both the activity of GRK2 and its ability to associate with mitochondria.<br/><br/>"We have a great opportunity here to develop new medicines against heart failure and improve upon this significant disease syndrome," he said. He added that this will take some time but that molecular and pharmacological strategies against GRK2 are in the works. "We are developing a gene therapy tool known as the ßARKct, which is a peptide inhibitor of GRK2, and are quite excited about a clinical trial."<br/><br/>Koch and his team have shown in pre-clinical studies that delivery of the ßARKct to failing hearts can inhibit GRK2 and thereby protect the heart from death. In the new study, ßARKct was found to block the enzyme's transit to mitochondria after ischemia, an important step now believed to contribute to the peptide's beneficial effects in heart failure.<br/><br/>There is much yet to learn about GRK2, however, according to Koch. "We still need to find out exactly what GRK2 is doing in the mitochondria," he said. "We need to figure out what it interacts with and specifically regulates."<br/><br/>What the team uncovers could solidify GRK2 as a key target for therapeutic strategies against heart disease.<br/><br/>Related Stories<br/><br/>Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Iowa researchers have previously shown that an enzyme called CaM kinase II plays a pivotal role in the death of heart cells following a heart attack or other conditions that damage or stress heart muscle. Loss | As enfermidades cardíacas en lugares inesperados, os investigadores descobren<br/><br/>Un factor importante no avance da enfermidade cardíaca é a morte do tecido cardíaco, un proceso que un equipo de científicos do Centro de Medicina Translacional da Universidade de Temple (TUSM) pensa que podería previrse con novos medicamentos. Agora, os investigadores están un paso máis preto de alcanzar ese obxectivo, grazas ao descubrimento dunha molécula clave nun lugar inesperado nas células do corazón: as mitocondrias, pequenas fábricas de enerxía que albergan os controis capaces de desencadear a secuencia de autodestrución das células.<br/><br/>O estudo é o primeiro en identificar a molécula, un encima coñecido como GRK2 (G protein-coupled receptor kinase 2), nas mitocondrias. Foi dirixido por Walter J. Koch, Ph.D., profesor e presidente do Departamento de Farmacoloxía da TUSM, e director do Centro de Medicina Translacional da TUSM.<br/><br/>"Sabemos que GRK2 está implicado no desenvolvemento patolóxico de certas enfermidades cardíacas, como a insuficiencia cardíaca crónica, e que a súa maior actividade pode levar á morte das células cardíacas. Pero o seu mecanismo para este último non estaba claro", dixo Koch. Ademais, aínda que se sabía que o encima estaba presente en niveis elevados nos corazóns de pacientes con insuficiencia cardíaca, as razóns do seu aumento non se entenderon completamente.<br/><br/>Normalmente, a GRK2 cuelga preto da membrana plasmática das células cardíacas, onde apaga certos sinais transferidos do sangue ao tecido. Pero os investigadores de Temple atoparon que se move ás mitocondrias en resposta a dúas características clásicas da enfermidade cardíaca, o insulto isquémico e o estrés oxidativo resultante. Estes dous procesos, nos cales un lapso momentáneo na entrega de sangue rico en oxíxeno a tecidos enfermos causa un aumento repentino nas moléculas reactivas daniñas, converxen para estimular o programa de autodestrución das células cardíacas. En última instancia, causan a morte de seccións enteiras do tecido cardíaco, deixando cicatrices que poden comprometer gravemente a capacidade do corazón para funcionar correctamente.<br/><br/>O equipo de Koch descubriu que nas células cardíacas isquémicas o movemento de GRK2 desde a membrana celular ata as mitocondrias é chaperonado por unha substancia chamada proteína de choque térmico 90 (Hsp90), que se produce nas células en resposta ao estrés. Ao bloquear a capacidade de Hsp90 de unirse á GRK2, os investigadores puideron impedir a entrega do encima ás mitocondrias.<br/><br/>Obtiveron o mesmo resultado despois de mutar un residuo chamado Ser670 no extremo da cola da estrutura de aminoácidos de GRK2. Cando o residuo Ser670 é activado por un sinal químico, Hsp90 é empurrado á acción, uníndose a GRK2 e transportándoo ás mitocondrias. A mutación de Ser670 tamén resultou nunha redución na sinalización pro-morte nas células cardíacas afectadas.Os efectos obsérvanse en células musculares cardíacas humanas cultivadas no laboratorio e en ratos que experimentaran ataques cardíacos inducidos. Os resultados están detallados na edición do 12 de abril da revista Circulation Research.<br/><br/>Koch explicou que a tradución dos novos achados á clínica, onde beneficiarían aos pacientes, reside no desenvolvemento de novos enfoques terapéuticos que son capaces de limitar tanto a actividade da GRK2 como a súa capacidade de asociarse coas mitocondrias.<br/><br/>"Temos unha gran oportunidade aquí para desenvolver novos medicamentos contra a insuficiencia cardíaca e mellorar esta síndrome de enfermidade significativa", dixo. Engadiu que isto levará algún tempo, pero que as estratexias moleculares e farmacolóxicas contra GRK2 están en traballo. "Estamos desenvolvendo unha ferramenta de terapia xénica coñecida como ßARKct, que é un inhibidor peptídico de GRK2, e estamos moi entusiasmados cun ensaio clínico".<br/><br/>Koch e o seu equipo demostraron en estudos preclínicos que a entrega do ßARKct a corazóns que fallan pode inhibir a GRK2 e, polo tanto, protexer o corazón da morte. No novo estudo, descubriuse que ßARKct bloquea o tránsito do encima ás mitocondrias despois da isquemia, un paso importante que agora se cre que contribúe aos efectos beneficiosos do péptido na insuficiencia cardíaca.<br/><br/>Aínda hai moito que aprender sobre a GRK2, con todo, segundo Koch. "Aínda temos que descubrir exactamente o que está facendo a GRK2 nas mitocondrias", dixo. "Necesitamos descubrir con que interactúa e regula especificamente".<br/><br/>O que o equipo descobre podería solidificar GRK2 como un obxectivo clave para estratexias terapéuticas contra as enfermidades cardíacas.<br/><br/>Historias relacionadas<br/><br/>A inhibición dunha proteína que se sabe que contribúe á insuficiencia cardíaca tamén parece ser protectora do corazón en lesións de estrés cardíaco máis agudas, é dicir, reperfusión isquémica, segundo dous estudos realizados no Centro para Iowa investigadores demostraron previamente que un encima chamado CaM quinase II xoga un papel fundamental na morte das células cardíacas despois dun ataque cardíaco ou outras condicións que danan ou estresan o músculo cardíaco. Perda |
| Slide 1: ==== ==== How To Cure Angular Cheilitis -- Success Guaranteed -- CLICK BELOW  ==== ====<br/>Angular cheilitis is an inflammatory lesion at the corner of the mouth and often occurs bilaterally. It is often characterized by cracks or deep fissures. In severe cases, the cracks may bleed when the mouth is opened and shallow ulcers or a crust may form. Although the sores of angular cheilitis may later become infected by the fungus Candida albicans or other pathogens, studies have linked the onset of angular cheilitis with nutritional deficiencies, particularly riboflavin (vitamin B 2) and iron deficiency, which in turn may be indicative of a poor diet or malnutrition. Zinc deficiency has also been associated with angular cheilitis. Other causes can be: the papilloma virus, stress, antibiotics, allergic substances and sunburn. How to treat angular cheilitis naturally at home:<br/>Keep your lips moisturized at all times: you can do that by applying unflavored lip balm or gloss or an aloe Vera gel. You can also use several natural home remedies, such as: Vitamin E: buy Vitamin E capsules and break them with a sterilized needle. Then apply the Vitamin E oil to the affected areas to treat cheilitis. Cucumber: just cut a piece of cucumber and rub it on your mouth. Neem leaf: rub neem leaf distill on the afflicted areas. Olive oil: Rub some olive oil over your lips. Honey: apply honey on your lips and wash it off after at least 15 minutes. Honey has excellent antibacterial properties and can help the healing process. Eat better and healthier: the best way to prevent and treat cheilitis is to nourish your body from the inside. Try to eat foods that are rich in vitamin B (brewer's yeast, legumes, fish, potatoes, peanuts, eggs, poultry, liver, meat, milk, brown rice, soybeans, butter and whole grain cereals) and iron (liver, oysters, pumpkin seeds, spinach, prunes, artichokes, canned beans, sardines and shrimps). An easy way to get all the vitamins you need for an effective angular cheilitis treatment is to take Vitamin B12 and Vitamin B1 supplements to boost your immune system and help your body fight off the bacteria and eliminate the disease. Avoid drinking orange juice: Orange juice is very acidic and can irritate the delicate skin at the corners of your mouth and also cause a lot of pain. If you really want to drink some orange juice, you can just use a straw. There are also other foods that can create irritation, such as spicy foods, lemonade and citrus fruits in general, so stay away from these foods, if you don't want to make this condition worse.<br/>Next find out the #1 method to Treat Angular Cheilitis Naturally! Just Click here to find out how!<br/>Slide 2: Article Source: <br/>==== ==== How To Cure Angular Cheilitis -- Success Guaranteed -- CLICK BELOW  ==== ==== | ========= Como curar a queilite angular -- Éxito garantido -- Prema abaixo =======<br/>A queilite angular é unha lesión inflamatoria na esquina da boca e a miúdo ocorre bilateralmente. A miúdo caracterízase por fisuras ou fisuras profundas. En casos graves, as fisuras poden sangrar cando se abre a boca e poden formarse úlceras pouco profundas ou unha codia. Aínda que as feridas da queilite angular poden infectarse máis tarde polo fungo Candida albicans ou outros patóxenos, os estudos relacionaron o inicio da queilite angular con deficiencias nutricionais, particularmente a riboflavina (vitamina B2) e a deficiencia de ferro, que á súa vez pode ser indicativa dunha dieta pobre ou desnutrición. A deficiencia de zinc tamén se asociou coa queilite angular. Outras causas poden ser: o virus do papiloma, o estrés, os antibióticos, as substancias alérxicas e as queimaduras solares. Como tratar a queilite angular naturalmente na casa:<br/>Mantén os beizos hidratados en todo momento: podes facelo aplicando bálsamo labial ou brillo sen sabor ou un xel de aloe vera. Tamén podes usar varios remedios naturais caseiros, como: Vitamina E: compra cápsulas de vitamina E e rompelas cunha agulla esterilizada. A continuación, aplique o aceite de vitamina E nas áreas afectadas para tratar a queilite. Pepino: só córtase un anaco de pepino e frótase na boca. Folla de neem: frótase folla de neem destilar nas áreas afectadas. Aceite de oliva: frótase un pouco de aceite de oliva sobre os beizos. Mel: aplicar mel nos beizos e lavalo despois de polo menos 15 minutos. O mel ten excelentes propiedades antibacterianas e pode axudar no proceso de curación. Comer mellor e máis saudable: a mellor forma de previr e tratar a queilite é nutrir o teu corpo desde dentro. Probe comer alimentos ricos en vitamina B (levedura de cervexa, legumes, peixe, patacas, cacahuetes, ovos, aves de corral, fígado, carne, leite, arroz integral, soia, manteiga e cereais enteiros) e ferro (fegado, ostras, sementes de abóbora, espinacas, ameixas, alcachofas, feixóns en conserva, sardiñas e shar). Unha forma sinxela de obter todas as vitaminas que precisa para un tratamento eficaz da queilite angular é tomar suplementos de vitamina B12 e vitamina B1 para aumentar o sistema inmunitario e axudar ao seu corpo a loitar contra as bacterias e eliminar a enfermidade. Evite beber zume de laranxa: o zume de laranxa é moi ácido e pode irritar a pel delicada nos recunchos da boca e tamén causar moita dor. Se realmente quere beber un pouco de zume de laranxa, só pode usar unha palla. Tamén hai outros alimentos que poden crear irritación, como alimentos picantes, limonada e cítricos en xeral, polo que mantéñase afastado destes alimentos, se non quere empeorar esta condición.<br/>A continuación, descubra o método #1 para tratar a queilite angular naturalmente! Prema aquí para descubrir como!<br/>Slide 2: Fonte do artigo:<br/>========= Como curar a queilite angular -- Éxito garantido -- CLICK BACK ======= |
| Kind Hearts And Cauliflowers<br/><br/>It sort of chokes you up when you think of the beautiful friendship between Jake Mintz and his boy, Wilf Greaves<br/><br/>Yet when Greaves retired last year and went to work on the Detroit docks, boxing men familiar with Jake Mintz's genius had not the slightest doubt that, had Jake lived on, he somehow would have finagled a shot at the world title for Wilf. Somehow he would have sneaked him beyond the edge. And who knows? Wilf might have met a champion on an off night and won the title. | Corazóns amables e coliflores<br/><br/>É unha especie de asfixia cando pensas na fermosa amizade entre Jake Mintz e o seu fillo, Wilf Greaves.<br/><br/>Con todo, cando Greaves retirouse o ano pasado e foi traballar nos peiraos de Detroit, os homes de boxeo familiarizados co xenio de Jake Mintz non tiñan a menor dúbida de que, se Jake vivise, dalgún xeito tería gañado o título mundial para Wilf. Quizais Wilf coñeceu a un campión nunha noite libre e gañou o título. |
| Featured ResearchShare ThisIntensive care patients are especially vulnerable to picking up infections in hospital, due to their poor health. Researchers from the Karolinska Institutet in Sweden found that 70% of intensive care patients studied were colonized with bacteria from other patients in the unit.<br/><br/>The researchers investigated the transmission of several strains of Staphylococcus bacteria, called CoNS. These strains are the primary cause of circulatory infections picked up in hospitals, and the third most common cause of all hospital infections. "These species have the ability to survive in the ICU surroundings on medical devices and equipment for weeks up to months," say the researchers. "They are specifically prone to causing catheter-related infections."<br/><br/>The team, led by Professor Charlotta Edlund, took swabs from the upper and lower airways of 20 intensive care patients that had required mechanical ventilation for at least three days. The researchers cultured the bacteria from these swabs and analysed the genetic fingerprints of Staphylococcus strains to identify bacteria that were identical or closely related. They could then assess the transmission rates of bacteria between patients, by seeing which patients harboured the same bacterial strains.<br/><br/>17 of the patients were colonised by CoNS during their hospital stay. In six of these cases, the bacteria had colonised the lower airways after the patient was ventilated, suggesting that the procedure itself had introduced the bacteria. 14 of the patients had either passed on a bacterial strain to another patient or received a bacterial strain from another patient. Worryingly, one patient passed on bacteria to a patient they had never met, having being discharged about three weeks prior to the other's arrival. This implies that the strain had survived in the ward during this period, perhaps on staff or on additional patients.<br/><br/>"Local guidelines for antibiotic use, close cooperation with infectious diseases specialists and restrictions with invasive treatment are strategies that can improve infection control and lower the incidence of hospital infections," write the authors. "Hand hygiene among hospital staff is [also] an important factor for preventing these infections."<br/><br/>The antibiotic resistance of the bacterial strains was analysed. 95% were resistant to penicillin, 86% to oxacillin, 48% to erythromycin, 42% to clindamycin, 54% to gentamicin, and 66% to ciprofloxacin. None were resistant to vancomycin, which is currently used to treat MRSA and other infections caused by other antibiotic-resistant bacteria.<br/><br/>Resistance to multiple antibiotics was commonly seen. 21% of the bacterial strains were resistant to six, 34% to at least five, and 59% to at least four of the tested antibiotics. "This multi-resistance will lead to higher consumption of broadspectrum antibiotics such as vancomycin, promoting the development of antibiotic resistance."<br/><br/>CoNS normally live on our skin without causing us any harm, but they can colonise airways or invasive devises (such as tubes used in mechanical ventilation), especially in people with weak immune systems. Although these bacteria do not always cause disease, colonisation is a risk factor for infection with other, more dangerous, antibiotic resistant bacterial strains. 13, 2011 — Expanded use of active surveillance for bacteria and of barrier precautions -- specifically, gloves and gowns -- did not reduce the transmission of two important antibiotic-resistant bacteria in ... full story<br/><br/>Feb. 24, 2011 — Infections are among the most frequent complications of a stay in hospital and raise the complication and mortality rates. New calculations have shown an incidence of almost 60,000 newly acquired | Os pacientes de coidados intensivos son especialmente vulnerables a contraer infeccións no hospital, debido á súa mala saúde. Investigadores do Karolinska Institutet en Suecia atoparon que o 70% dos pacientes de coidados intensivos estudados foron colonizados con bacterias doutros pacientes da unidade.<br/><br/>Os investigadores investigaron a transmisión de varias cepas de bacterias Staphylococcus, chamadas CoNS. Estas cepas son a principal causa de infeccións circulatorias recollidas nos hospitais, e a terceira causa máis común de todas as infeccións hospitalarias. "Estas especies teñen a capacidade de sobrevivir no entorno da UCI en dispositivos e equipos médicos durante semanas ata meses", dicindo os investigadores. "Eles son especialmente propensos a causar infeccións relacionadas co catéter."<br/><br/>O equipo, liderado pola profesora Charlotta Edlund, tomou hisopos das vías respiratorias superior e inferior de 20 pacientes de coidados intensivos que requiriran ventilación mecánica durante polo menos tres días. Os investigadores cultivaron as bacterias a partir destes hisopos e analizaron as pegadas xenéticas das cepas de Staphylococcus para identificar bacterias que eran idénticas ou estreitamente relacionadas. A continuación, puideron avaliar as taxas de transmisión de bacterias entre os pacientes, vendo que pacientes albergaban as mesmas cepas bacterianas.<br/><br/>17 dos pacientes foron colonizados por CoNS durante a súa estadía hospitalaria. En seis destes casos, a bacteria colonizou as vías respiratorias inferiores despois de que o paciente fose ventilado, suxerindo que o procedemento en si introduciu a bacteria. Catorce dos pacientes transmitiran unha cepa bacteriana a outro paciente ou recibiran unha cepa bacteriana doutro paciente. Preocupantemente, un paciente pasou as bacterias a un paciente que nunca coñecera, sendo dado de alta unhas tres semanas antes da chegada do outro. Isto implica que a cepa sobrevivira na sala durante este período, quizais no persoal ou en pacientes adicionais.<br/><br/>"As directrices locais para o uso de antibióticos, a estreita cooperación con especialistas en enfermidades infecciosas e as restricións co tratamento invasivo son estratexias que poden mellorar o control da infección e reducir a incidencia de infeccións hospitalarias", escriben os autores. "A hixiene das mans entre o persoal do hospital é [tamén] un factor importante para previr estas infeccións".<br/><br/>Analizouse a resistencia a antibióticos das cepas bacterianas: 95% eran resistentes á penicilina, 86% á oxacilina, 48% á eritromicina, 42% á clindamicina, 54% á gentamicina e 66% á ciprofloxacina. Ningunha delas era resistente á vancomicina, que actualmente se usa para tratar o SARM e outras infeccións causadas por outras bacterias resistentes aos antibióticos.<br/><br/>O 21% das cepas bacterianas eran resistentes a seis, o 34% a polo menos cinco e o 59% a polo menos catro dos antibióticos probados. "Esta multi-resistencia levará a un maior consumo de antibióticos de amplo espectro como a vancomicina, promovendo o desenvolvemento de resistencia a antibióticos".<br/><br/>Os CoNS normalmente viven na nosa pel sen causarnos ningún dano, pero poden colonizar vías respiratorias ou dispositivos invasivos (como os tubos utilizados na ventilación mecánica), especialmente en persoas con sistemas inmunitarios débiles. Aínda que estas bacterias non sempre causan enfermidades, a colonización é un factor de risco para a infección con outras cepas bacterianas máis perigosas e resistentes aos antibióticos. O uso expandido de vixilancia activa para as bacterias e de precaucións de barreira, especificamente, luvas e vestidos, non reduciu a transmisión de dúas bacterias importantes resistentes a antibióticos en todo o mundo.<br/><br/>24 de febreiro de 2011 — As infeccións están entre as complicacións máis frecuentes dunha estadía hospitalaria e aumentan as taxas de complicación e mortalidade. Novos cálculos mostraron unha incidencia de case 60.000 recentemente adquiridos |
| Some Amish and Mennonites suffer rare genetic problems<br/><br/>Some Amish and Mennonite individuals struggle with genetic conditions little-seen in the general population. Certain Amish populations also exhibit diseases and conditions seen elsewhere, but at a higher rate than the general public. Amish and related groups have been assisted by outsiders in treating genetic problems.<br/><br/>What genetic diseases are common among Amish and Mennonites?<br/><br/>Amish and Mennonites exhibit certain rare diseases uncommon in other populations. These include Ellis-van Creveld syndrome (a type of dwarfism), glutaric aciduria, Crigler-Najjar syndrome, and maple syrup urine disease. Some illnesses are so uncommon that they are unique to these communities (such as Troyer Syndrome or Amish lethal microcephaly), or rarely seen elsewhere.<br/><br/>Some groups of Amish may exhibit diseases more likely to be seen in the general public, but at a higher rate. These include cystic fibrosis, muscular dystrophy and deafness in some communities.<br/><br/>Amish suffer genetic problems for a few reasons:<br/><br/>Small founding groups-individual Amish communities typically originate from relatively few families. Almost all of the Amish in Lancaster County, for example, originated from a few dozen 18th-century immigrant families.<br/><br/>Genetic isolation-converts to the Amish have been rare, and Amish only marry other Amish. This practice of endogamy, with few new bloodlines entering the population, has led to limited variation of genes.<br/><br/>Lancaster Amish descend from a small group of 18th-century immigrants<br/><br/>These two factors combine to create a "founder effect". A founder effect means that genetic variation is lost over time due to a limited number of founding individuals. Certain recessive traits found in a small founding population are amplified in future generations.<br/><br/>Additionally, most Amish tend to focus religious energies on their own sizeable families, as opposed to proselytizing others. These two factors make it unlikely for outsiders to join the Amish, a process by which the Amish genetic pool would otherwise be deepened over time.<br/><br/>Help for Amish and Mennonites with hereditary illnesses<br/><br/>Amish and outsiders sympathetic to their challenges have focused on early diagnosis and treatment of genetic illnesses in their communities. A number of institutions assist Amish and Mennonite families afflicted by inherited genetic disorders.<br/><br/>The Clinic for Special Children Benefit Auction is held annually in a number of places, including Leola in Lancaster County<br/><br/>The best-known is The Clinic for Special Children, located in Strasburg in Lancaster County. The Clinic, run by Dr. Holmes Morton, operates thanks to contributions, proceeds from annual benefit auctions taking place in Pennsylvania and Ohio, and by charging relatively small fees for services. The Clinic for Special Children also treats children from outside the Amish and Mennonite community and from around the world.<br/><br/>Other medical institutions, such as the Akron, Ohio Children's Hospital and the SUNY Upstate Medical University accommodate Amish and Mennonite patients, as in the case of cystic fibrosis treatment, for example.<br/><br/>Researchers fairly frequently enlist Amish help in conducting genetic studies, such as recent research on the presence of a "fat gene" in Amish individuals. Amish, increasingly aware of the benefits genetic research can bring to others and themselves, generally participate in large numbers.<br/><br/>Intermarriage across Amish society may be another solution to genetic issues, as Amish in different communities exhibit different bloodlines. However, differences in practice between Amish affiliations may prevent such intermarriage from occurring. Marriage between communities such as Lancaster County and Holmes County, Ohio, occur only rarely.<br/><br/>Enjoy this post? Subscribe by email to get updates from Amish America:<br/><br/>Related Articles to Do Amish have genetic disorders?<br/><br/>Genetic Treatment in the Plain Population You may be aware of the Clinic for Special Children in Strasburg, Pennsylvania, which treats children suffering from rare genetic illnesses, primarily within the Amish and Mennonite populations. The clinic…<br/><br/>Do we romanticize the Amish? When I first began spending time with the Amish, I felt like I was entering another world. I would drive my car from gritty Decatur, Illinois, where I was living…<br/><br/>Do Amish practice inbreeding? Today's question springs from a new study on a genetic mutation which causes a form of mental retardation among Amish. Like other genetic research involving the Amish, this study will probably…<br/><br/>Amish Tech Conference registration now open As mentioned before, this spring the Young Center for Anabaptist and Pietist Studies at Elizabethtown College will be hosting a 3-day conference entitled "Amish America: Plain Technology in a Cyber…<br/><br/>4 responses to Do Amish have genetic disorders?<br/><br/>I am doing a research paper on Amish genetic disorders and was wondering if there was more to the article listed above, or if you have nay more inforamtion regarding this topic. If you could contact me, I would appreciate it greatly. I can also be reached by phone at 302-690-4427. Thank you for your time.<br/><br/>In over 25 years living in an Amish community, I've witnessed a distressing and frightening array of genetic disorders among the children. Recently, however, I attended a presentation by a snake oil salesman who could have come straight out of a Gunsmoke episode. He insisted none of the maladies afflicting the children or others are genetic. He claimed they're all caused by dietary deficiencies. It was a throwback to the dark ages. If they bought his "nutrition supplements" then it would cure epilepsy, muscular dystrophy, downes syndrome and impotency, among others. He is misleading people and will injure them. Whats to be done with this fraud?<br/><br/>Has there been any effort toward education regarding the claims of the "snake oil" salesman? So many times people (or their families)who have been affected by a disorder that they cannot personally control are vulnerable to anything that comes along that feel gives some measure of managing the problem.<br/>Considering the practices of raising families inside a very small gene pool, it is a certainty that the incidence of these disorders will increase.<br/>Very sad.<br/><br/>Is there proof that these supplements wouldn't work? Perhaps not for some of these conditions, but other supplements have been well known to help aid a body to cure itself of a disease, such as cancer, Fibromyalgia (I hear a rising occurrence among the Amish), MS, Diabetes, etc. Remember that these supplements (if a good quality) may very well be those vitamins and minerals that we are lacking in modern diets, and the Amish diet in many places can be lacking, though I know many are as concerned about mainstream diets and their deficiencies. We have a doctor in Colorado who is primarily homeopathic but has his medical degree. He has a very high success rate using supplements and raw foods/juices to rid the body of cancer and other ailments, such as Fibromyalgia. And supplements and essential oils are all natural medicines given to us by God and largely overlooked by the population at large. Something that may appear to be "snake oil" to some, may very well be exactly what is needed. I don't know the individual persons, so I can't really comment on that. Recently, a purdue study showed that the fruit of the Soursop (graviola) tree killed cancer cells 10,000 times better than chemo drugs. Why is it not known? It could never be synthesized. They tried for seven years. | Algúns amish e menonitas sofren problemas xenéticos raros.<br/><br/>Algúns individuos amish e menonitas loitan con condicións xenéticas pouco vistas na poboación xeral, e certas poboacións amish tamén exhiben enfermidades e condicións vistas noutros lugares, pero a un ritmo máis alto que o público en xeral. Os grupos amish e afines foron axudados por estranxeiros no tratamento de problemas xenéticos.<br/><br/>Que enfermidades xenéticas son comúns entre os amish e os menonitas?<br/><br/>Os amish e menonitas exhiben certas enfermidades raras pouco comúns noutras poboacións, como a síndrome de Ellis-van Creveld (un tipo de nanismo), a aciduria glutárica, a síndrome de Crigler-Najjar e a enfermidade da ouriña do xarope de bordo. Algunhas enfermidades son tan raras que son únicas para estas comunidades (como a síndrome de Troyer ou a microcefalia letal amish), ou raramente se ven noutros lugares.<br/><br/>Algúns grupos de Amish poden exhibir enfermidades máis propensas a verse no público en xeral, pero a un ritmo máis alto. Estes inclúen fibrose quística, distrofia muscular e xordeira nalgunhas comunidades.<br/><br/>Os Amish sofren problemas xenéticos por algunhas razóns:<br/><br/>Pequenos grupos fundadores -comunidades Amish individuais- adoitan orixinarse de relativamente poucas familias, case todos os Amish do condado de Lancaster, por exemplo, orixinaron unhas poucas ducias de familias inmigrantes do século XVIII.<br/><br/>Esta práctica de endogamia, con poucas liñaxes novas entrando na poboación, levou a unha limitada variación de xenes.<br/><br/>Lancaster Amish descende dun pequeno grupo de inmigrantes do século XVIII.<br/><br/>Estes dous factores combínanse para crear un "efecto fundador". Un efecto fundador significa que a variación xenética pérdese co tempo debido a un número limitado de individuos fundadores. Certos trazos recesivos atopados nunha pequena poboación fundadora son amplificados nas xeracións futuras.<br/><br/>Ademais, a maioría dos Amish tenden a centrar as enerxías relixiosas nas súas propias familias, en lugar de proselitismo outros. Estes dous factores fan improbable que os estranxeiros se unan aos Amish, un proceso polo cal a reserva xenética Amish se profundizaría co tempo.<br/><br/>Axuda para Amish e Menonitas con enfermidades hereditarias<br/><br/>Os Amish e os estranxeiros que simpatizan cos seus desafíos centráronse no diagnóstico precoz e no tratamento de enfermidades xenéticas nas súas comunidades. Varias institucións axudan ás familias Amish e menonitas aflixidas por trastornos xenéticos herdados.<br/><br/>A subasta de beneficios especiais para nenos da Clínica celébrase anualmente en varios lugares, incluíndo Leola no condado de Lancaster.<br/><br/>A máis coñecida é a Clínica para Nenos Especiais, situada en Strasburg, no condado de Lancaster. A Clínica, dirixida polo Dr. Holmes Morton, opera grazas a contribucións, procede de poxas de beneficios anuais que teñen lugar en Pensilvania e Ohio, e cobrando taxas relativamente pequenas por servizos. A Clínica para Nenos Especiais tamén trata nenos de fóra da comunidade Amish e Menonita e de todo o mundo.<br/><br/>Outras institucións médicas, como o Akron, Ohio Children's Hospital e a SUNY Upstate Medical University acollen a pacientes Amish e menonitas, como no caso do tratamento da fibrose quística, por exemplo.<br/><br/>Os investigadores recrutan con bastante frecuencia a axuda dos Amish na realización de estudos xenéticos, como investigacións recentes sobre a presenza dun "xene de graxa" en individuos Amish. Os amish, cada vez máis conscientes dos beneficios que a investigación xenética pode traer aos demais e a si mesmos, participan xeralmente en gran número.<br/><br/>Os matrimonios mixtos en toda a sociedade Amish poden ser outra solución a problemas xenéticos, xa que os Amish en diferentes comunidades exhiben diferentes liñaxes de sangue. Os matrimonios entre comunidades como o Condado de Lancaster e o Condado de Holmes, Ohio, ocorren só raramente.<br/><br/>Gústache este post? Subscríbete por correo electrónico para recibir actualizacións de Amish America:<br/><br/>Os Amish teñen trastornos xenéticos?<br/><br/>Tratamento xenético na poboación llana Pode ser consciente da Clínica para nenos especiais en Strasburg, Pensilvania, que trata nenos que sofren de enfermidades xenéticas raras, principalmente entre as poboacións amish e menonita. A clínica...<br/><br/>Cando empecei a pasar tempo cos Amish, sentín que estaba entrando noutro mundo. Conducía o meu coche desde Decatur, Illinois, onde vivía...<br/><br/>Práctica Amish endogamia? A pregunta de hoxe brota dun novo estudo sobre unha mutación xenética que causa unha forma de atraso mental entre os Amish. Como outras investigacións xenéticas que implican aos Amish, este estudo probablemente...<br/><br/>Como se mencionou anteriormente, esta primavera o Centro de Mozos para Anabaptistas e Estudos Pietistas no Elizabethtown College será a anfitriona dunha conferencia de 3 días titulada "Amish America: Plain Technology in a Cyber...<br/><br/>4 respostas a Teñen os Amish trastornos xenéticos?<br/><br/>Estou a facer un traballo de investigación sobre os trastornos xenéticos amish e pregúntome se había máis do artigo listado anteriormente, ou se tes máis inforamtion sobre este tema. Se me podes contactar, agradeceríao moito. Tamén podo ser contactado por teléfono no 302-690-4427. Grazas polo seu tempo.<br/><br/>En máis de 25 anos vivindo nunha comunidade Amish, testemuñei unha serie angustiante e aterradora de trastornos xenéticos entre os nenos. Recentemente, porén, asistín a unha presentación dun vendedor de aceite de serpe que podería saír directamente dun episodio de Gunsmoke. El insistiu en que ningunha das enfermidades que aflixen aos nenos ou a outros son xenéticas. Afirmou que todos son causados por deficiencias dietéticas. Foi un retroceso ás idades escuras. Se compraban os seus "suplementos nutricionais" entón curaría a epilepsia, a distrofia muscular, a síndrome de Downes e a impotencia, entre outros. Está enganando á xente e farálles dano. Que facer con esta fraude?<br/><br/>Houbo algún esforzo para a educación con respecto ás afirmacións do vendedor de "petróleo de serpe"? Moitas veces as persoas (ou as súas familias) que se viron afectadas por un trastorno que non poden controlar persoalmente son vulnerables a calquera cousa que chegue que che dea algunha medida de xestionar o problema.<br/>Considerando as prácticas de criar familias dentro dun conxunto de xenes moi pequeno, é certo que a incidencia destes trastornos aumentará.<br/>Moi triste.<br/><br/>Hai probas de que estes suplementos non funcionan? Quizais non para algunhas destas condicións, pero outros suplementos foron ben coñecidos para axudar a axudar a un corpo a curarse dunha enfermidade, como o cancro, a fibromialxia (escoito unha aparición crecente entre os amish), EM, diabetes, etc. Lembre que estes suplementos (se é de boa calidade) poden ser as vitaminas e minerais que nos faltan nas dietas modernas, e a dieta Amish en moitos lugares pode faltar, aínda que sei que moitos están tan preocupados polas dietas tradicionais e as súas deficiencias. Temos un médico en Colorado que é principalmente homeopático pero ten o seu título de médico. Ten unha taxa de éxito moi alta usando suplementos e alimentos / zumes crus para librar o corpo do cancro e outras doenzas, como a fibromialxia. E os suplementos e aceites esenciais son todos medicamentos naturais que Deus nos deu e que a poboación en xeral pasa por alto. Algo que pode parecer "aceite de serpe" para algúns, pode moi ben ser exactamente o que se necesita. Non coñezo as persoas individuais, polo que realmente non podo comentar sobre iso. Recentemente, un estudo purdue mostrou que a froita da árbore Soursop (graviola) matou as células cancerosas 10.000 veces mellor que as drogas de quimioterapia. Por que non se sabe? Nunca se puido sintetizar. Intentaron facelo durante sete anos. |
| Which political party in the United States has claimed to represent the interests of the working class and the disadvantaged since the early 1900s?<br/>A. the Democratic Party<br/>B. the Libertarian Party<br/>C. the Progressive Party<br/>D. the Republican Party<br/><br/>A. the Democratic Party is political party in the United States that has claimed to represent the interests of the working class and the disadvantaged since the early 1900s | Que partido político nos Estados Unidos reclamou representar os intereses da clase obreira e os desfavorecidos desde principios do século XX?<br/>A. O Partido Democrático<br/>Partido Libertario<br/>O Partido Progresista<br/>D. Partido Republicano<br/><br/>O Partido Demócrata é un partido político dos Estados Unidos que afirma representar os intereses da clase obreira e os desfavorecidos desde principios do século XX. |
| It's not functioning like a normal shuffle does. it processes through the songs, but does not catch a song after the shuffle starts. Also, if I press a song to play without shuffle, it flashes the song, then goes back to the playlist.<br/><br/>The same songs on my macbook and ipad work fine, both under shuffle and next-advance mode.<br/><br/>My iPhone 5 has the exact same problem (and it's only about one month old). In shuffle mode, with the "shake to shuffle" off and just the "x" selected, if I try to skip ahead one song, it skips three or four songs and then just stops randomly at whichever song it wants to. This needs to be fixed. Very annoying | Non funciona como un shuffle normal. Procesa as cancións, pero non captura unha canción despois de que comece o shuffle. Ademais, se premo unha canción para reproducir sen shuffle, parpadea a canción e logo volve á lista de reprodución.<br/><br/>As mesmas cancións no meu Macbook e iPad funcionan ben, tanto en modo shuffle como next-advance.<br/><br/>O meu iPhone 5 ten exactamente o mesmo problema (e só ten un mes de idade). No modo shuffle, co "shake to shuffle" apagado e só o "x" escollido, se intento saltarme unha canción, salta tres ou catro cancións e logo párase aleatoriamente en calquera canción que queira. Isto ten que ser corrixido. Moi molesto |
